Cardiovascular manifestations secondary to COVID-19: A narrative review - 17/06/22
Abstract |
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly, becoming a major threat to global health. In addition to having required the adaptation of healthcare workers for almost 2 years, it has been much talked about, both in the media and among the scientific community. Beyond lung damage and respiratory symptoms, the involvement of the cardiovascular system largely explains COVID-19 morbimortality. In this review, we emphasize that cardiovascular involvement is common and is associated with a worse prognosis, and that earlier detection by physicians should lead to better management. First, direct cardiac involvement will be discussed, in the form of COVID-19 myocarditis, then secondary cardiac involvement, such as myocardial injury, myocardial infarction and arrhythmias, will be considered. Finally, worsening of previous cardiovascular disease as a result of COVID-19 will be examined, as well as long-term COVID-19 effects and cardiovascular complications of COVID-19 vaccines.
El texto completo de este artículo está disponible en PDF.Keywords : COVID-19, Cardiovascular system
Abbreviations : ACE2, AF, CHF, CMR, COVID-19, LV, MI, mRNA, OHCA, PE, RV, SARS-CoV-2, STEMI
Esquema
Vol 81
Artículo 100904- mai 2022 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.